Survivin is a 16.5 kDa protein that is expressed during the G2/M phase of the cell cycle and is hypothesized to inhibit a default apoptotic cascade initiated in mitosis. This inhibitory function is coupled to survivin's localization to the mitotic spindle. To begin to address the structural basis of survivin's function, we report the X-ray crystal structure of a recombinant form of full length survivin to 2.58 Å resolution. Survivin consists of two defined domains including an N-terminal Zn2+-binding BIR domain linked to a 65 Å amphipathic C-terminal α-helix. The crystal structure reveals an extensive dimerization interface along a hydrophobic surface on the BIR domain of each survivin monomer. A basic patch acting as a sulfate/phosphate-binding module, an acidic cluster projecting off the BIR domain, and a solvent-accessible hydrophobic surface residing on the C-terminal amphipathic helix, are suggestive of functional protein–protein interaction surfaces.
Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Protein Data Bank
Li, F., et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580–583 ( 1998).
Tamm, I., et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58, 5315–5320 ( 1998).
Liston, P., et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379, 349– 353 (1996).
Uren, A. G., Pakusch, M., Hawkins, C.J., Puls, K.L. & Vaux, D.L. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc. Natl. Acad. Sci USA 93, 4974–4978 (1996).
Deveraux, Q. L. & Reed, J.C. IAP family proteins-suppressors of apoptosis. Genes Dev. 13, 239– 252 (1999).
Ambrosini, G., Adida, C. & Altieri, D. C., A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med. 3, 917– 921 (1997).
Li, F., et al. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nature Cell Bio. 1, 461– 466 (1999).
Tanaka, K., et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer Res. 6, 127– 134 (2000).
Monzo, M., et al. A Novel Anti-Apoptosis Gene: Re-expression of Survivin Messenger RNA as a Prognosis Marker in Non-Small-Cell Lung Cancers. J. Clinic Oncology 7, 2100 (1999).
Kawasaki, H., et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58, 5071– 5074 (1998).
Lu, C., Altieri, D. C. & Tanigawa, N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 58, 1808–1812 ( 1998).
Jäätelä, M. Escaping Cell Death: Survival Proteins in Cancer. Exp. Cell Res. 248, 30–43 ( 1999).
Sun, C., et al. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature 401, 818–822 ( 1999).
Hinds, M.G., Norton, R.S., Vaux, D.L. & Day, C.L. Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat. Nature Struct. Biol. 6, 648–651 ( 1999).
Hozak, R.R., Manji, G.A. & Friesen, P.D. The BIR motifs mediate dominant interference and oligomerization of inhibitor of apoptosis Op-IAP. Mol. Cell. Biol. 20, 1877–1885 (2000).
Fraser, A. G., James, C., Evan, G.I. & Hengartner, M.O. Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Current Biol. 9, 292 –301 (1999).
Uren, A.G., et al. Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division . Proc. Natl. Acad. Sci. USA 96, 10170– 10175 (1999).
Xu, X., et al. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3, 389–395 (1999).
Roy, N., Deveraux, Q.L., Takahashi, R., Salvesen, G.S. & Reed, J. C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16, 6914– 6925 (1997).
Suzuki, A., et al. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 19, 1346–1353 (2000).
Jez, J. M., Ferrer, J-L., Bowman, M. E., Dixon, R. A. & Noel, J. P. Dissection of malonyl-coenzyme A decarboxylation from polyketide formation in the reaction mechanism of a plant polyketide synthase. Biochemistry 39, 890– 902 (2000).
Johnson, M. L., Correia, J. J., Yphantis, D.A. & Halvorson, H.R. Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques. Biophys. J. 36, 575– 588 (1981).
Philo, J.S. An improved function for fitting sedimentation velocity data for low-molecular weight solutes. Biophys. J. 72, 435– 444 (1997).
Stafford, W.D. Boundary analysis in sedimentation transport experiments: a procedure for obtaining sedimentation coefficient distributions using the time derivative of the concentration profile. Anal. Biochem. 203, 295– 301 (1992).
Otwinowski, Z. & Minor, W. Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 , 307–326 (1997).
Collaborative Computational Project, Number 4. CCP4 Suite: programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994).
Terwilliger, T. C. & Berendzen, J. Automated MAD and MIR structure solution. Acta Crystallogr. D 55, 849– 861 (1999).
McRee, D. E. A visual protein crystallographic software system for X11/Xview. J. Mol. Graph. 10, 44–46 ( 1992).
de La Fortelle, E. & Bricogne, G. Maximum likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anamolous diffraction methods. Methods Enzymol. 276, 472–494 (1997).
Abrahams, J. P. & Leslie, A. G. W. Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallogr. D 52, 30–42 ( 1996).
Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. D 49, 148–157 (1993).
Cowtan, K. D. & Main, P. Improvement of macromolecular electron-density maps by the simultaneous application of real and reciprocal space constraints . Acta Crystallogr. D 54, 487– 493 (1993).
Brunger, A. T. et al. Crystallography and NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905 –921 (1998).
Laskowski, R. A., MacArthur. M. W., Moss, D. S. & Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures . J. Appl. Crystallogr. 26, 283– 291 (1993).
Mittl, P. R. E. et al. Structure of recombinant human CPP32 in complex with the tetrapeptideacetyl-Asp-Val-Ala-Asp fluoromethyl ketone. J. Biol. Chem. 272, 6539–6547 (1997).
Nicholls, A., Charp, K. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Protein Struct. Funct. Genet. 11, 281–296 (1991).
Kraulis, P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures . J. Appl. Crystallogr. 24, 946– 950 (1991).
Amundsen, S. et al. X-POV-Team POV-Ray: persistence of vision ray-tracer. http://www.povray.org. (1997).
Jones, G., Jones, D., Zhou, L., Steller, H. & Chu, Y. Deterin, a new inhibitor of apoptosis from Drosophila melanogaster. J. Biol. Chem. Apr 11 [epub ahead of print] (2000).
We thank J. Greenwald for assistance performing light scattering experiments. We also thank W. Jiang for providing a HeLa cell cDNA library. The SSRL Biotechnology Program is supported by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and by the Department of Energy, Office of Biological and Environmental Research. This work was supported by USPHS grants awarded to J.P.N. and T.H. T.H. is a Frank and Else Schilling American Cancer Society Professor. H.-k.H. is supported by a fellowship from the Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation.
About this article
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
Journal of Experimental & Clinical Cancer Research (2019)
Journal of Cell Science (2019)
Medicinal Research Reviews (2019)
Overexpression of apoptosis-related protein, survivin, in fibroblasts from patients with systemic sclerosis
Irish Journal of Medical Science (1971 -) (2019)
Journal of Cellular Physiology (2019)